Institutional investors purchased a net $1.9 million shares of EDAP during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 25.29% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 2.0 Million shares of Edap Tms SA